Skip to content
thestock.space

Inventurus Knowledge Solutions (IKS) had a P/E of 35.4× on 6 Nov 2026, above the industry P/E of 26.0×, and the shares are 16% below their 52-week high. Sales and net profit grew 46% and 33% a year over 3 years; its ROCE of 30% is the highest among its 5 Health Information Services peers. Debt is 1.75× equity. It is a small-cap company with a market cap of ₹27,799 Cr, the largest of 6 Health Information Services companies by market cap; the shares rose 5.4% over the past year.

As of 6 Nov 2026Prices are delayed about 15 minutes; fundamentals are from the quarter ended Jun 2026.How we calculate this

past year
Open
₹1,726.90
Day high
₹1,726.90
Day low
₹1,627.80
Prev. close
₹1,757.20
Volume
1.8 L

Health check

3 good · 3 to check
  • ReturnsAhead

    +5.4% over a year, better than 4 of 5 peers.

  • Price tagPricier

    P/E 35.4 vs industry 26.0.

  • GrowthStrong

    Sales +45.7%, profit +33.2% a year over 3 years.

  • ProfitabilityStrong

    ROCE 29.6% vs peer median 12.5%.

  • Balance sheetStretched

    Debt 1.75× equity, interest covered 13.9×, Piotroski 5 of 9.

  • Red flags1 to check

    Debt is 1.75× equity.

Compared with 5 industry peers. Computed from reported figures. Educational, not a recommendation.

Health Information Services

5 listed peers. Screen the industry

Small cap

₹27,799 Cr, the largest of 6 in its industry.

Market sensitivity

Measuring against the NIFTY 50…

Key metrics

Last 12 months to Jun 2026: sales ₹4,181 Cr · profit ₹801 Cr
Market cap
₹27,799 Cr
Small cap
P/E
35.4
Industry 26.0
Price to book
8.32
Peers 1.98
Dividend yield
0.00%
ROE
28.2%
Peers 12.9%
ROCE
29.6%
Peers 12.5%
Debt to equity
1.75
Debt ₹5,959 Cr
EPS (TTM)
₹46.83
Face value ₹1
OPM (TTM)
33.7%
Net margin 19.1%
Sales growth
+20.7%
Latest quarter vs a year ago
Profit growth
+27.8%
Latest quarter vs a year ago
Price to sales
6.65
EV/EBITDA 26.8

Strengths and risks

Strengths

  • Return on equity of 28.2%.
  • Return on capital employed of 29.6%.
  • Quarterly profit up 27.8% on a year ago.
  • Quarterly sales up 20.7% on a year ago.
  • Positive operating cash flow in each of the last 4 years.

Risks to check

  • Debt is 1.75× equity.

Derived automatically from reported figures. Not a recommendation.

About Inventurus Knowledge Solutions

Inventurus Knowledge Solutions Limited operates as a technology-enabled healthcare solutions provider. The company offers a care enablement platform and associated services predominantly to healthcare enterprises in the United States, Canada, and Australia. The company offers a platform that serves healthcare organizations, including health systems/ integrated delivery networks, academic medical centers, multi-specialty medical groups, single-specialty…

Headquarters
Navi Mumbai
Employees
9,698
Sector
Healthcare
ISIN
INE115Q01022
Website
ikshealth.com

Price range

52 weeks

₹1,262.00₹1,970.00

Today

₹1,627.80₹1,726.90
Avg volume (3M)
1.6 L
1-year return
plus 5.4%
From 52-week high
minus 15.9%

Analyst consensus

9 analysts
No consensusMean target ₹2,023.33 plus 22.1%

Target range, with today’s price

Low ₹1,730.00High ₹2,230.00

Today’s price ₹1,657.10 is below the lowest analyst target.

Consensus from Yahoo Finance. Not a recommendation.

Peers · Health Information Services

Compare with peersScreen the whole industry
Company
IKSInventurus Knowledge Solutions1,657.10minus 5.70%27,79935.48.3229.6%28.2%33.7%45.7%33.2%0.00%plus 5.4%
SAGILITYSagility43.46minus 0.78%20,34519.81.9812.5%10.7%24.4%19.5%86.0%0.69%minus 15.1%
INDGNIndegene609.75minus 0.59%14,68435.94.3715.3%13.2%16.5%15.0%14.7%0.37%plus 13.8%
FABTECHFabtech Technologies131.98minus 1.78%58715.51.2111.8%12.9%2.4%28.3%20.8%0.45%minus 43.5%
TAKETAKE12.57plus 4.84%18632.26.1015.4%42.1%−0.9%−34.1%–0.00%minus 49.8%
DEEPAIDeep Health AI India1.640.00%2414.90.653.2%3.1%−457.4%−17.9%−3.4%12.20%minus 81.9%
Median of 5 peers–−0.59%58719.81.9812.5%12.9%2.4%15.0%17.7%0.45%−43.5%

Quarterly results

Consolidated, ₹ crore
SalesSelect a row below to chart it
₹ CrMar 25Jun 25Dec 25Mar 26Jun 26
724740815858894
–––+18.5%+20.7%
498502533557599
226238282300295
31.2%32.1%34.6%35.0%33.0%
3.33.13.2−0.50.4
2118.123.312.710.1
28.327.93234.134.3
180195229253251
17.9%22.2%20.1%18.6%22.8%
148152183206194
–––+39.4%+27.8%
8.708.8510.7312.0611.32

Sep 25 not reported by the data source.

Profit & loss

Yearly, ₹ crore
Sales CAGR 3Y
+45.7%
Profit CAGR 3Y
+33.2%
EPS CAGR 3Y
+33.4%
ROE
28.2%
Net profitSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
1,0311,8172,6643,194
–+76.2%+46.6%+19.9%
6361,2921,8962,163
3955257681,030
38.3%28.9%28.8%32.3%
26.430.115.168
5.458.988.970.1
24.658.5113124
−32.34.525.10.6
359442606905
15.1%16.1%19.8%20.3%
305370486722
–+21.4%+31.2%+48.4%
17.7921.5928.6242.26

Forecast

Your assumptions, not a prediction

Balance sheet

At each financial year end, ₹ crore
Total assetsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
16.816.91717.1
8121,1411,7732,783
52.31,311856753
107559407715
9883,0283,0524,268
57.6158130147
–1.55.71
12453.91146
523484192609
2832,3312,6103,504
9883,0283,0524,268

Cash flow

Yearly, ₹ crore
Cash from operationsSelect a row below to chart it
₹ CrMar 2023Mar 2024Mar 2025Mar 2026
288210318674
−156−1,141244−210
−152780−389−412
−20.2−15117351.8
−8.6−32.7−42.4−60.6
279177276613
–−165––

Shareholding pattern

Source: NSE filings
63.7%
promoters
  • Promoters63.72%
  • Public34.09%
  • Employee trusts2.19%
  • As of 30 Sep 2026
QuarterSplitPromotersPublicPromoter change
30 Sep 202663.72%34.09%0.00
30 Jun 202663.72%34.05%0.00
31 Mar 202663.72%33.97%0.00
31 Dec 202563.72%33.91%0.00
30 Sep 202563.72%33.82%–

Major shareholders

NSE filing

Filings & events

News

No recent news coverage found.

My notes

Private to you